add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
Hemolytic-uremic syndrome quincymedgroup.com | Hemolytic-uremic syndrome - Adventist HealthCare adventisthealthcare.com | Jefferson University Hospital - Hemolytic Uremic Syndrome content.jeffersonhospital... | Hemolytic Uremic Syndrome childrens.com |
"HUS" redirects here. For other uses, see Hus.
In medicine, hemolytic-uremic syndrome (or haemolytic-uraemic syndrome, abbreviated HUS) is a disease characterized by hemolytic anemia, acute renal failure (uremia) and a low platelet count (thrombocytopenia). It predominantly but not exclusively affects children. Most cases are preceded by an episode of diarrhea caused by E. coli O157:H7, which is acquired as a foodborne illness. It is a medical emergency and carries a 5–10% mortality; of the remainder, the majority recover without major consequences but a small proportion develop chronic kidney disease and become reliant on renal replacement therapy.[1] HUS was first defined as a syndrome in 1955.[2][3]
[edit] Signs and symptomsE. coli O157:H7 increases risk of hemolytic-uremic syndrome.[4] [edit] Childhood HUSHUS is part of thrombotic microangiopathies that encompass Thrombotic thrombocytopenic purpura (TTP) and HUS. The classic childhood case of HUS occurs after bloody diarrhea caused by a strain of E. coli that expresses verotoxin (also called Shiga-like toxin) which is known as SPEC (Shiga-producing E. coli) or EHEC (Enterohemorrhagic E. coli). HUS follows an influenza-like or gastrointestinal (GI) prodrome with bleeding manifestations (especially hematemesis and melena), severe oliguria, hematuria, a microangiopathic hemolytic anemia, and (in some patients) prominent neurologic changes.[5] A somewhat less common form of HUS (~10% of cases) does not follow SPEC infection and is thought to result from factor H deficiency (a complement regulatory protein) that results in uncontrolled complement activation after minor endothelial injury resulting in thrombosis.[6] In the classical form (90% of cases), the SPEC toxin enters the bloodstream, attaches to glomerular endothelium (blood vessel cell lining of kidney), causing damage to blood vessels (not just in the kidneys but in all tissues of the body), and initiates a non-inflammatory reaction leading to acute renal failure (ARF) and platelet activation that causes thrombocytopenia (low platelet count). The typical pathophysiology involves the shiga-toxin binding to proteins on the surface of glomerular endothelium and inactivating a metalloproteinase ADAMTS13 (which is also involved in TTP). Once the ADAMTS13 is disabled multimers of vWF form and initiate platelet activation and cause microthrombi formation. In contrast with typical Disseminated intravascular coagulation (DIC) seen with other causes of septicemia and occasionally with advanced cancer, coagulation factors are not consumed in HUS (or TTP) and the coagulation screen, fibrinogen level, and assays for fibrin degradation products such as "D-Dimers", are generally normal despite the low platelet count (thrombocytopenia). The arterioles and capillaries of the body become obscured by a resulting mesh of activated platelets which have adhered to endothelium via large multimeric vWF. As well as consuming platelets, this mesh thrombi destroys red blood cells as they squeeze through the narrowed blood vessels forming schistocytes (sheared RBC's) (which is a prominent feature used for diagnosis). This mechanism known as "microangiopathic hemolysis" which has been likened to the effect of a cheesewire or garotte across the vessel lumen. This can lead to severe thrombocytopenia. As in the related condition thrombotic thrombocytopenic purpura (TTP), reduced blood flow through the narrowed blood vessels of the microvascular leads to reduced blood flow to vital organs and ischemia may develop. As the kidneys and the central nervous system (brain and spinal cord) are the parts of the body most critically dependent on high blood flow, they are the most likely organs to be affected. However, in comparison to TTP, the kidneys tend to be more severely affected in HUS, and the central nervous system is less commonly affected. The usual age of onset is between 2 years and adolescence. Grossly, the kidneys may show patchy or diffuse renal cortical necrosis. Histologically, the glomeruli show thickened and sometimes split capillary walls due largely to endothelial swelling. Large deposits of fibrin-related materials in the capillary lumens, subendothelially, and in the mesangium are also found along with mesangiolysis. Interlobular and afferent arterioles show fibrinoid necrosis and intimal hyperplasia and are often occluded by thrombi.[7] HUS occurs after 2-7% of all E. coli O157:H7 infections. [edit] Adult HUSAdult HUS has similar symptoms and pathology but is an uncommon outcome of the following: HIV; antiphospholipid syndrome (associated with Lupus erythematosus and generalized hypercoagulability); post partum renal failure; malignant hypertension; scleroderma; and certain drugs including some chemotherapy drugs and other immunosuppressive agents (mitomycin, ciclosporin, cisplatin and bleomycin). [edit] Familial HUSA third category is referred to as familial HUS. It represents 5-10% of HUS cases[citation needed] and is largely due to mutations in the complement proteins factor H, membrane cofactor protein and factor I[8] leading to uncontrolled complement system activation. Recurrent thromboses result in a high mortality rate. [edit] DiagnosisClinically, HUS can be very hard to distinguish from thrombotic thrombocytopenic purpura (TTP). The laboratory features are almost identical, and not every case of HUS is preceded by diarrhea. HUS is characterized by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure. The only distinguishing feature is that in TTP, fever and neurological symptoms are often present; but this is not always the case. The two conditions are sometimes treated as a single entity called "TTP/HUS".[9][10] However, some dispute this grouping, and TTP is now known to be caused by an acquired defect in the protein ADAMTS13.[11] [edit] Treatment
Antibiotic treatment of E. coli O157:H7 colitis may stimulate further verotoxin production and thereby increase the risk of HUS.[12][13] Treatment is generally supportive with dialysis as needed. However untreated HUS in adults may progress to end organ damage. Platelet transfusion may actually worsen outcome. In most children with post-diarrheal HUS, there is a good chance of spontaneous resolution and hence observation in hospital is often all that is necessary, with supportive care such as hemodialysis where indicated. In children with neurological or other non-renal involvement, and in adult cases particularly when there is diagnostic uncertainty between HUS and TTP, plasmapheresis ("plasma exchange") is the treatment of choice. This is generally performed daily until the platelet count is normal, using fresh frozen plasma as the replacement fluid for the patient's plasma which is removed. Plasmapheresis may reverse the ongoing platelet consumption. [edit] PrognosisWith aggressive treatment > 90% survive acute phase. About 9% may develop end stage renal disease. About one-third of persons with hemolytic-uremic syndrome have abnormal kidney function many years later, and a few require long-term dialysis. Another 8% of persons with hemolytic uremic syndrome have other lifelong complications, such as high blood pressure, seizures, blindness, paralysis, and the effects of having part of their colon removed. The overall mortality rate from HUS is 5-15%. Children and the elderly have a worse prognosis.[14] [edit] EpidemiologyHUS has a peak incidence between 6 months and 4 years of age.[1] HUS and the E. coli infections which caused it have been the source of much negative publicity for the Food and Drug Administration (FDA), meat industries, and fast-food restaurants since the 1990s, especially in the Jack in the Box contaminations. It was also featured in the Robin Cook novel Toxin. In 2006, an epidemic of harmful E. coli emerged in the United States due to contaminated spinach. 183 known cases have been reported, including 29 cases of HUS. In June, 2009, Nestle Toll House "cookie dough" was linked to an outbreak of E. coli 0157:H7 in the United States, which sickened 70 people in 30 states.[1] [edit] See also[edit] References
[edit] External links
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ↑ top of page ↑ | about thumbshots |
